T8	Effect 17 76	a sharp rise in International Normalized Ratio (INR) values
T10	Subject 84 93	a patient
T11	Treatment 96 163	concomitant use of warfarin and the antineoplastic agent vismodegib
T13	Drug 115 123	warfarin
T14	Drug 153 163	vismodegib
T9	Adverse_event 77 83	during
T12	Combination 96 107	concomitant
E1	Adverse_event:T9 
E2	Combination:T12 arg:T13 arg2:T14